Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2014, vol. 23, nr 3, May-June, p. 475–484

Publication type: review article

Language: English

Epidemiology, Diagnostics and Treatment of Vascular Tumours and Malformations

Piotr Wójcicki1,A,D,E,F, Karolina Wójcicka1,A,B,C,D,F

1 Clinic of Plastic Surgery, Wroclaw Medical University, Polanica Zdrój, Poland

Abstract

Vascular tumours and vascular malformations are common vasculose anomalies characteristic for dissimilar clinical course, specific biological as well as immune cytological and histological properties. Vascular lesions classification system and their detailed division into groups and subgroups were elaborated and implemented in Rome, in 1996, during meeting of the International Society for the Study of Vascular anomalies (ISSVa). It was based on modification of an earlier going division by Mullikien and Głowacki from 1982. Infantile hemangiomas are the most numerous group of benign tumours of mesenchymal origin. Vascular malformations appear definitely less often. They are composed of normal endothelium lined displastic vessels which originate from vascular tissue abnormal morphogenesis. In contrast, in hemangiomas, at the proliferation stage, increased, multiplication of endothelial cells is observed as well as of fibroblasts, mastocytes and macrophages. Infantile hemangiomas are usually not present at the moment of birth and white chloasma with superficial teleangiectasis appears which increases within 3–4 weeks and gets bright red colour and reveal very characteristic clinical course basing on intensive growth period and involution long process. Vascular malformations are observed most often at the delivery moment or they may appear at an early childhood. They enlarge proportionally along with the child’s growth and their sudden expansion may be triggered by an infection, hormonal changes or trauma. Contrary to hemangiomas, they do not subside spontaneously and their abrupt increase may result in impairment or deformation of important anatomical structures. Infantile hemangiomas and vascular malformations require different and individual treatments which are often multi-stage procedures carried on in specialistic centres of plastic surgery, vascular surgery or maxillofacial surgery.

Key words

vascular tumours, vascular malformations, infantile hemangiomas, vascular anomalies.

References (64)

  1. Jacobs AH, Walton RG: The incidence of birthmarks in the neonate. Pediatrics 1976, 58, 218–221.
  2. Amir J, Metzker A, Krikler R: Strawberry hemangioma in preterm infants. Pediatr dermatol 1986, 3, 331–332.
  3. Enjorlas O, Wassef M, Chapot R: Color atlas of vascular tumors and vascular malformations. Cambridge University Press, Cambridge 2007.
  4. Mulliken JB, Zetter BR, Folkman J: In vitro characteristic of endothelium from hemangiomas and vascular malformations. Surgery 1982, 92, 348–353.
  5. Wyrzykowski D, Chrzanowska B, Czauderna P: Congenital vascular anomalies in preand perinatal period of life-management and treatment options. arch Perinatal Med 2011, 17, 85–92.
  6. Finn MC, Glowacki J, Mulliken JB: Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983, 18, 894–900.
  7. Szymik-Kantorowicz S. Naczyniaki – co o nich wiemy? adv Clin Exp Med 2005, 14, 129–136.
  8. Mulliken JB: State of the art and future trends-round table on hemangiomas. 10th International Workshop on Vascular anomalies, Budapest June 1994.
  9. Grochowski J, Szymik-Kantorowicz S: Nieprawidłowości naczyń obwodowych u dzieci. Chirurgia tętnic i żył obwodowych. Red. Noszczyk W, PZWL, Warszawa 1998, 502–508.
  10. Chang LC, Haggstrom AN, Drolet BA: Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008, 122, 360–367.
  11. Mulliken JB, Głowaacki J: Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982, 69, 412–422.
  12. Chamlin SL, Haggstrom AN, Drolet BA: Multicenter prospective study of ulcerated hemangiomas. J Pediatr 2007, 151, 684–689.
  13. Takahashi K, Mulliken JB, Kozakewich H, Harry P, Rogers R, Folkman J, Ezekowitz R: Cellular markers that distinguish the phases of hem angioma Turing infanci and childhood. J Clin Invest 1994, 93, 2357–2364.
  14. Nakayama H. Clinical and histological studies of the classification and the natural course of the strawberry mark. L dermatol 1981, 2, 277–291.
  15. Smoller BR, Apfelberg DB: Infantile (juvenile) capillary haemangioma: a tumor of heterogeneous cellular elements. J Cutan Pathol 1993, 20, 330–336.
  16. Sznurkowska K, Wyrzykowski D: Naczyniaki u dzieci – problem interdyscyplinarny. forum Med Rodz 2011, 5, 460–467.
  17. Fishman SJ, Mulliken JB: Hemangiomas and vascular malformations of infancy and childhood. Pediatr Surg 1993, 40, 1177–1200.
  18. Boyd JB, Mulliken JB, Kaban LB: Sceletal changes associated with vascular malformations. Plast Reconstr Surg 1984, 74, 789–797.
  19. Enjolras O, Mulliken JB: Vascular tumors and vascular malformations (new issues). adv dermatol 1998, 13, 375–423.
  20. Enjolras O, Wassef M, Chapot R. Color atlas of vascular tumors and vascular malformations. Cambridge Univeristy Press, Cambridge 2007.
  21. Przewratil P: Naczyniaki krwionośne – aktualne teorie dotyczące patogenezy. Prz Pediatr 2009, 39, 39–41.
  22. Yu Y, Flint AF, Mulliken JB, Wu JK, Bischoff J: Endothelial progenitor cells in infantile hemangioma. Blood 2004, 103, 1373–1375.
  23. Frischer JS, Huang J, Serur A, Kadenhe A, Yamaschiro DJ, Kandel JJ: Biomolecular markers and involution of hemangiomas. J Pediatr Surg 2004, 39, 400–404.
  24. Walsh DA: Pathophysiological mechanism of angiogenesis. adv Clin Chem 2007, 44, 187–221.
  25. Zhang GY, Yi CHG, Li X, Liang ZQ, Wang RX, Liu DE, Zhang LM, Meng CY, Guo SZ: Proliferation hemangiomas formation through dual mechanism of vascular endothelial growth factor mediated endothelial progenitor cells proliferation and mobilization through matrix metlloproteinases 9. Med Hypoth 2008, 70, 815–818.
  26. Yu Y, Varughese J, Brown LF, Mulliken JB, Bischoff J: Increased Tie2 expression enhanced response to angiopoietin-1 and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. am J Pathol 2001, 159, 2271–2280.
  27. Ritter MR, Dorell MI, Edmonds J, Friedlander SF, Friedlander M: Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large scale expression analysis. Proc Natl acad Sci USa 2002, 99, 7455–7460.
  28. North PE, Waner M, Mizeracki A, Mihm MC: GLUT-1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000, 31, 11–22.
  29. Burton BK, Schulz CJ, Angle B, Burd LI: an increased incidence of hemangiomas in infants born following chorionic villus sampling (CVS). Prenatal diagn 1995, 15, 189–195.
  30. Lui W, Zhang S, Hu T, Wei F, Gao Y, Cheng N: Sex hormone receptors of hemangiomas in children. Chin Med J (Engl) 1997, 110, 349–351.
  31. Dadras SS, North PE, Bertoncini J, Mihm MC, Detmar M: Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol 2004, 17, 1068–1079.
  32. Freiden IJ, Reese V, Cohen D: PHaCE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects and eye abnormalities. arch dermatol 1996, 132, 307–311.
  33. Enjorlas O, Wassef M, Mzoyer E, Frieden IJ, Rieu P, Drouet L, Taleb A, Stalder J, Escante J: Infants with Kasabach-Merritt syndrome do not have „ true” hemangiomas. J Pediatr 1997, 130, 631–640.
  34. Johnston M: Radioautographic study of the migration and fate of cranial neural crests in the chick embryo. anat Rec 1966, 156, 143–155.
  35. Mulliken JB, Young A: Vascular Birthmarks: Hemangiomas and Malformations. WB Saunders, Philadelphia 1988.
  36. Nozue T, Tsuzaki M: further studies on distribution of neural crest cells in prenatal or postnatal development in mice. Okajimas folia anat Jpn 1974, 51, 131–160.
  37. Enjolras O, Riché MC, Merland JJ: facial port-wine stains and Sturge-Weber syndrome. Pediatrics 1985, 76, 48–51.
  38. Greene AK, Taber SF, Ball KL: Sturge-Weber syndrome: frequency and morbidity of facial overgrowth. J Craniofac Surg 2009, 20, 617–621.
  39. Cobb S: Haemangioma of the spinal cord associated with skin nevi of the same metamere. ann Surg 1915, 62, 641–649.
  40. Mulliken JB, Fishman SJ, Burrows PE: Vascular anomalies. Curr Prob Surg 2000, 37, 517–584.
  41. Sabin F: On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. am J anat 1902, 1, 367–389.
  42. McGill TJ, Forsen JW, Mulliken JB: Hemangiomas and vascular anomalies of head and neck. Pediatr Otolaryng Head and Surg. Vol 5, cap V. Mosby, New York 1998, 66–80.
  43. Padwa BL, Hayward PG, Ferraro NF: Cervicofacial lymphatic malformation: clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg 1995, 95, 951–960.
  44. Gorham L, Stout A: Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone): its relation to hemangiomatosis. J Bone Joint Surg am 1955, 37, 986–1004.
  45. Boon LM, Mulliken JB, Enjolras O: Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. arch dermatol 2004, 140, 971–976.
  46. Upton J, Coombs CJ, Mulliken JB: Vascular malformations of the upper limb: a review of 270 patients. J Hand Surg (am) 1999, 24, 1019–1035.
  47. Halsted W: Congenital arteriovenous and lymphaticovenous fistulae: unique clinical and experimental observations. Proc Natl acad Sci USa 1919, 5, 76–79.
  48. Gomes MM, Bernatz PE: arteriovenous fistulae: a review and ten-year experience at the Mayo Clinic. Mayo Clin Proc 1970, 45, 81–102.
  49. Holman E: The physiology of an arteriovenous fistula. am J Surg 1955, 89, 1101–1108.
  50. Liu AS, Mulliken JB, Zurakowski D: Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg 2010, 125, 1185–1194.
  51. Masuda H, Zhuang YJ, Singh TM: adaptive remodeling of internal elastic lamina and endothelial lining during flow-induced arterial enlargement. arterioscler Thromb Vasc Biol 1999, 19, 2298–2307.
  52. Kohout MP, Hansen M, Pribaz JJ: arteriovenous malformations of the head and neck: Natural history and management. Plast Reconstr Surg 1998, 102, 643–654.
  53. Léauté-Labrèze C: Propranolol for severe hemangiomas of infancy. N Engl J Med 2008, 358, 2649–2661.
  54. Taban M: Propranolol for orbital hemangioma. Opthalmology 2010, 117, 195.
  55. Fay A: Propranolol for isolated orbital infantile hemangioma. arch Opthalmol 2010, 128, 256–258.
  56. Hermans DJ: Propranolol in a case series of 174 patients with complicated infantile hemangoma: indications, safety and future directions. Br J dermatol 2013, 168, 837–843.
  57. Wyrzykowski D, Chojnicki M: Zastosowanie propranololu w leczeniu naczyniaków wczesnodziecięcych – doświadczenia własne. Standardy Medyczne/Pediatria 2010, 7, 100–105.
  58. Alison B: Infantile hemangiomas: a review. Saudi J Opthalmol 2012, 26, 283–291.
  59. Andrzejewska E, Bacewicz L: Zastosowanie propranololu w leczeniu naczyniaków krwionośnych wczesnodziecięcych – program wieloośrodkowej oceny skuteczności. Badania Wieloośrodkowe w Ogólnopolskim Rejestrze Chirurgii Noworodka.
  60. Ortiz AE, Nelson JS: Port-wine stain laser treatments and novel approaches. facial Plast Surg 2012, 28, 611–620.
  61. Werner JA, Lippert BM: Ultrasound-guided interstitial Nd: Yag laser treatment of voluminous hemangiomas and vascular malformations in 92 patients. Laryngoscope 1998, 108, 463–470.
  62. Alvarez-Camino JC, Espana-Tost AJ: Endoluminal sclerosis with diode laser in the treatment of orofacial venous malformations. Med Oral Patol Oral Cir Bucal 2013 1, 18, 486–490.
  63. Klein A, Baumler W: a randomized controlled trial to optimize indocyanine gree-augmented diode laser therapy of capillary malformations. Lasers Surg Med 2013, 45, 216–224.
  64. Wolfenson M, Norberto dos Santos Fiho FC: Scar treatment with fractional laser. Plast Recostr Surg 2012, 130, 908–910.
© Wroclaw Medical University